SOMA LABS, INC. VS. MANAVKUMAR G. SHAH (C-000114-13, MIDDLESEX COUNTY AND STATEWIDE)

New Jersey Superior Court Appellate Division·Decided May 13, 2019·No. A-4685-16T1·Unpublished

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION

DOCKET NO. A-4685-16T1

SOMA LABS, INC., Plaintiff-Respondent,

v.

MANAVKUMAR G. SHAH and VITACARE PHARMA, LLC, f/k/a VITACARE LABS, LLC,

Defendants-Appellants,

and

PRIME PACK, LLC, d/b/a PRIME PHARMACEUTICALS,

Defendant.

Argued January 31, 2019 – Decided May 13, 2019 Before Judges Simonelli, O'Connor and DeAlmeida.

On appeal from Superior Court of New Jersey, Chancery Division, Middlesex County, Docket No. C-

000114-13.

Susheela V. Verma argued the cause for appellants (Law Offices of Susheela Verma, attorneys; Susheela V. Verma, of counsel and on the brief; Mildred V.

Spiller, on the brief).

Larry E. Hardcastle, II, argued the cause for respondent (Lanciano & Associates, LLC, attorneys; Larry E.

Hardcastle, II, on the brief).

PER CURIAM In this matter, plaintiff Soma Labs, Inc. (Soma) alleged that its former employee, defendant Manavkumar G. Shah, misappropriated its trade secrets and breached a confidentiality and non-solicitation agreement by, in part, soliciting Soma's major customer on behalf of Shah's business, defendant VitaCare Pharma, LLC (VitaCare), a competitor of Soma.1 Defendants prevailed at trial, but appeal from the March 13, 2015 Chancery Division order denying their motion for leave to amend their answer to assert a counterclaim against Soma and a third-party complaint against Soma's principal, John Botzolakis. Defendants also appeal from two separate May 22, 2017 orders denying their motion for frivolous litigation sanctions pursuant to N.J.S.A.

1 We shall sometimes collectively refer to Shah and VitaCare as defendants.

A-4685-16T1

2A:15-59.1 and Rule 1:4-8, and their motion for fee-shifting under the New Jersey Trade Secrets Act (NJTSA), N.J.S.A. 56:15-1 to -9.2 We affirm.

I.

We first address the denial of defendants' motions for frivolous litigation sanctions under N.J.S.A. 2A:15-59.1 and Rule 1:4-8. The following facts inform our review.

Soma manufactures custom dietary supplements known as nutraceuticals, which it ships to its customers who then sell them to the public under the customers' brand names and labels. Nutraceuticals are foods or tablets containing health-giving additives. To create a nutraceutical tablet, "[i]n general, you take a mixed blend; you put it into the hoppers of a tablet machine; get the weight, the hardness, the thickness. And once it's approved by the lab, then it's run." However, in order to create the "mixed blend," the "manufacturer must determine whether the formula is directly compressible in a tablet press or will require granulation before it is compressible."

2 Defendants also appealed from the June 18, 2015 order denying their motion for reconsideration of the March 13, 2015 order; however, they failed to address this issue in their merits brief. The issue, therefore, is deemed waived. See Sklodowsky v. Lushis, 417 N.J. Super. 648, 657 (App. Div. 2011); Pressler & Verniero, Current N.J. Court Rules, cmt. 5 on R. 2:6-2 (2019).

A-4685-16T1

"Directly compressible means you can take that mixture, mix it, and put it directly onto the tablet machine; it will run it." Where granulation is required, "[i]t means the flow may be bad, the compressibility may not be good; everything. There’s a list of things that may not allow the material to be compressed." Further, granulation is a lengthier process, taking "at least [twenty], [twenty-five]" hours more than direct compression.

Soma claimed it developed two processes, alleged to be trade secrets, which would permit direct compression of mixtures otherwise requiring granulation. The first purported trade secret was used to introduce moisture into the mixture through a completely dry ingredient (the 1:1 trade secret). The second purported trade secret eliminated undesirable tablet characteristics that would otherwise have to be eliminated through granulation (the ratio trade secret).

Shah learned of the two processes during his employment with Soma. In November 2008, Shah executed a confidentiality and non-solicitation agreement (agreement), which precluded him from disclosing or using any of Soma's confidential information and trade secrets, soliciting any of Soma's customers for a three-year period following termination of his employment, or hiring any of Soma's employees.

A-4685-16T1

Shortly after Shah's resignation in January 2011, Soma analyzed his computer and discovered that he removed some of Soma's confidential information while still employed, having sent it from his work email address to his personal email address. Soma also discovered that Shah forwarded additional Soma business information to his personal email address after his resignation and that defendants had hired a former Soma employee.

Soma later discovered, in June 2013, that Shah had solicited a "large"

customer of Soma, discussing pricing for manufacturing nutraceuticals. As a result, Soma filed a complaint against defendants asserting claims for breach of the duty of loyalty, misappropriation of confidential and proprietary information, tortious interference with contract, tortious interference with prospective economic advantage, breach of contract, breach of the implied covenant of good faith and fair dealing, unjust enrichment, violation of the Computer System Act, N.J.S.A. 2A:38A-1 to -6, and misappropriation of trade secrets. Soma later filed an amended complaint adding claims of conversion, violation of the NJTSA, and fraudulent concealment and destruction of evidence.

The parties engaged in extensive motion practice during this litigation.

Defendants repeatedly argued before Judge Frank M. Ciuffani that Soma's trade

A-4685-16T1

secrets claims were frivolous and "nothing more than a hoax" to harass defendants and stifle competition. Notably, however, defendants consented to the entry of temporary restraints, enjoining them, in part, from "using or disclosing any confidential or proprietary information of [Soma,]" which remained in effect throughout the litigation. In addition, Soma withstood defendants' motion for partial summary judgment, attempts to bar Soma's expert, and defendants' motion for involuntary dismissal at the close of Soma's evidence.

Soma's central claim was that defendants misappropriated Soma's trade secrets. Defendants' expert testified at the trial that the 1:1 trade secret was actually a process in the public domain referred to as "moisture activated dry granulation." He also testified that the ratio trade secret was in the public domain, pointing to a nutraceutical product line, available at Walmart, that he believed utilized the ratio trade secret in its manufacturing process.

Judge Ciuffani ultimately held that Soma failed to prove that the 1:1 trade secret and ratio trade secret were trade secrets or that Shah took trade secrets. In reaching this conclusion, the judge found Soma failed to protect the confidentiality of the purported trade secrets. For example, Soma did not have contractors or visitors at its facility sign confidentiality agreements; Soma

A-4685-16T1

utilized the purported trade secrets prior to 2008, several years before to having its employees execute confidentiality agreements; and Soma did not adequately designate formulations and other protocols as trade secrets. The judge credited the testimony of defendants' expert that the two purported trade secrets were in the public domain. The judge also found that Shah took Soma's confidential information, but did not use it to compete against Soma.

Free access — add to your briefcase to read the full text and ask questions with AI

SOMA LABS, INC. VS. MANAVKUMAR G. SHAH (C-000114-13, MIDDLESEX COUNTY AND STATEWIDE), (N.J. Ct. App. 2019).

SOMA LABS, INC. VS. MANAVKUMAR G. SHAH (C-000114-13, MIDDLESEX COUNTY AND STATEWIDE) (SOMA LABS, INC. VS. MANAVKUMAR G. SHAH (C-000114-13, MIDDLESEX COUNTY AND STATEWIDE)) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

McKeown-Brand v. Trump Castle Hotel & Casino
626 A.2d 425 (Supreme Court of New Jersey, 1993)
Fagas v. Scott
597 A.2d 571 (New Jersey Superior Court App Division, 1991)
First Atlantic Federal Credit Union v. Perez
918 A.2d 666 (New Jersey Superior Court App Division, 2007)
Ferolito v. Park Hill Association
975 A.2d 473 (New Jersey Superior Court App Division, 2009)
Kernan v. One Washington Park Urban Renewal Associates
713 A.2d 411 (Supreme Court of New Jersey, 1998)
Masone v. Levine
887 A.2d 1191 (New Jersey Superior Court App Division, 2005)
FRANKLIN MED. v. Newark Public Sch.
828 A.2d 966 (New Jersey Superior Court App Division, 2003)
Seidenberg v. Summit Bank
791 A.2d 1068 (New Jersey Superior Court App Division, 2002)
Sons of Thunder, Inc. v. Borden, Inc.
690 A.2d 575 (Supreme Court of New Jersey, 1997)
Wilson v. Amerada Hess Corp.
773 A.2d 1121 (Supreme Court of New Jersey, 2001)
DeBrango v. Summit Bancorp
745 A.2d 561 (New Jersey Superior Court App Division, 2000)
LoBiondo v. Schwartz
970 A.2d 1007 (Supreme Court of New Jersey, 2009)
Notte v. Merchants Mutual Insurance
888 A.2d 464 (Supreme Court of New Jersey, 2006)
Yield Dynamics, Inc. v. TEA Systems Corp.
66 Cal. Rptr. 3d 1 (California Court of Appeal, 2007)
United Hearts, LLC v. Zahabian
971 A.2d 434 (New Jersey Superior Court App Division, 2009)
Gemini Aluminum Corp. v. California Custom Shapes, Inc.
116 Cal. Rptr. 2d 358 (California Court of Appeal, 2002)
Horowitz v. Weishoff
787 A.2d 236 (New Jersey Superior Court App Division, 2001)
Belfer v. Merling
730 A.2d 434 (New Jersey Superior Court App Division, 1999)
Trocki Plastic Surg. Ctr. v. Bartkowski
782 A.2d 447 (New Jersey Superior Court App Division, 2001)
Lipkowitz v. Hamilton Surgery Ctr.
999 A.2d 1199 (New Jersey Superior Court App Division, 2010)